Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

NCT03219372 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT03219372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03219372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
Lead sponsor
Cedars-Sinai Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
September 27, 2018
Completion date
March 5, 2019
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver cirrhoses